U.S. Markets open in 14 mins.

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
28.50-0.21 (-0.73%)
At close: 4:02PM EDT
People also watch
MYLGILDNVSAMGNABT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue21,903,00019,652,00020,272,00020,314,000
Cost of Revenue9,661,0008,296,0009,216,0009,598,000
Gross Profit12,242,00011,356,00011,056,00010,716,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses16,232,00014,505,00015,806,00016,344,000
Operating Income or Loss5,671,0005,147,0004,466,0003,970,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes5,671,0005,147,0004,466,0003,970,000
Interest Expense-546,000-270,000-300,000-314,000
Income Before Tax----
Income Tax Expense521,000634,000591,000-43,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income329,0001,588,0003,055,0001,269,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----